Resveratrol researcher Dipak Das: My lab’s work was “99% correct”

Das, via UConn

Dipak Das, the UConn red wine researcher charged by his institution with rampant misconduct that will likely lead to dozens of retractions, is evidently a 99%-er — when it comes to accuracy, that is.

According to a statement purportedly from his lawyer refuting those charges, Das claims, among other things, that the output from his lab was nearly perfect. He also has a lot to say about a 60,000-page report that the statement says he may not have actually downloaded.

We might note a lot more things about the letter, which we received from Bill Sardi, president of Longevinex, a resveratrol company which has worked with Das. Sardi has been sending Das defenses since the story broke; we posted some of them and Derek Lowe has posted parts of another. But here’s the letter, in its entirety: Continue reading Resveratrol researcher Dipak Das: My lab’s work was “99% correct”

Should Iran have nuclear power? Paper addressing question retracted for authorship issues

When Renewable and Sustainable Energy Reviews accepted a paper last year arguing that nuclear power is Iran’s “assured right,” the editor, Lawrence Kazmirski, thought the article would be at least somewhat controversial. He was right — but for the wrong reason.

Shortly after publication, Kazmirski,  director of the National Center for Photovoltaics at the National Renewable Energy Laboratory, in Golden, Colo., received an email from one of the listed co-authors of the article complaining that he and another co-author had not consented to submit the work. Kazmirski contacted the lead author, Afshin Mazandarani, who agreed to withdraw the paper.

The result was the following notice, which appeared in October (we only recently saw it): Continue reading Should Iran have nuclear power? Paper addressing question retracted for authorship issues

Journal of Neurochemistry retracts paper after SUNY Upstate medical school finds evidence of fraud

Following an investigation by the State University of New York (SUNY) Upstate into the work of one of its neuroscientists, the Journal of Neurochemistry has retracted a 2007 paper.

The retraction notice is quite clear about why the paper is being withdrawn: Continue reading Journal of Neurochemistry retracts paper after SUNY Upstate medical school finds evidence of fraud

Mysterious retraction in the Journal of Biological Chemistry for Takashi Tsuji’s group

The authors of a paper in the Journal of Biological Chemistry (JBC) have retracted it, but don’t ask us why.

This being the JBC, the retraction notice for “Human T-cell Leukemia Virus Type I Tax Down-regulates the Expression of Phosphatidylinositol 3,4,5-Trisphosphate Inositol Phosphatases via the NF-κB Pathway” is the very definition of opaque: Continue reading Mysterious retraction in the Journal of Biological Chemistry for Takashi Tsuji’s group

Seeing double: Current Eye Research retracts three papers for duplication

Three papers in Current Eye Research have apparently not quite lived up to the journal’s name. The journal in November retracted three studies from a group of authors in China who had previously published the papers in their native language.

Here’s the notice, which also appears in this month’s print edition: Continue reading Seeing double: Current Eye Research retracts three papers for duplication

Orthopedics plagiarist may have lied about affiliation

Earlier this year we reported on the case of Bernardino Saccomanni, an apparently shameless plagiarist with a fondness for publishing in the orthopedics literature.

Somehow, we’re not surprised to learn that Saccomanni may not have been totally above board in other ways, too.

According to Robert Lindsay, editor of Osteoporosis International, whose journal has retracted one of Saccomanni’s plagiarized manuscripts, the researcher’s stated affiliation on several recent papers — Gabriele D’ Annunzio University Chieti — had long ago severed ties with him: Continue reading Orthopedics plagiarist may have lied about affiliation

Sebastiani and Perls longevity genes work finds a new home in PLoS ONE following Science retraction

via Wikimedia

Today, without us having planned it, has become the day of retracted papers that found a new home.

This morning, we posted an item about a chimp “culture” paper that was retracted from Biology Letters after its authors found some errors, and then published, with corrections, in the Journal of Human Evolution. This afternoon, we bring you the news of a PLoS ONE paper on longevity genes that is the corrected version of a Science paper retracted last year: Continue reading Sebastiani and Perls longevity genes work finds a new home in PLoS ONE following Science retraction

Chimp ‘culture’ paper retracted after authors spot errors, now has home at another journal

The authors of a 2011 paper claiming that chimp “culture” has more to do with local habitats than with where the chimps live have retracted it after finding mistakes in their work.

Here’s the notice for the paper, “Variation in chimpanzee ‘culture’ is predicted by local ecology, not geography:” Continue reading Chimp ‘culture’ paper retracted after authors spot errors, now has home at another journal

ORI roundup: Former SUNY grad student, two Kansas U researchers hit with sanctions

In two unrelated cases, the Office of Research Integrity (ORI) has sanctioned a grad student and a pair of colleagues, one of whom plagiarized and the other allowed the intellectual theft to go unchecked.

We think the handling of these cases — both first noted briefly by The Chronicle of Higher Education — is worth noting.

Continue reading ORI roundup: Former SUNY grad student, two Kansas U researchers hit with sanctions

Your experiment didn’t work out? The Journal of Errology wants to hear from you

It’s no secret that it can be difficult to find negative results in the scientific literature. For a variety of reasons, positive publication bias is a real phenomenon. In clinical medicine, that can paint a more optimistic picture of a field than is actually the case. And in basic science, it can mean other scientists may repeat experiments that have already failed.

But the new Journal of Errology, yet to be launched, wants to be a home for experiments that didn’t work out. If it’s successful, it might mean a place where researchers could publish results that don’t look great, without feeling the need to make them look any better — a strategy that can lead to retractions.

BioFlukes, the journal’s Bangalore, India-based publishers, have ambitious goals, according to the company’s Mahboob Imtiyaz: Continue reading Your experiment didn’t work out? The Journal of Errology wants to hear from you